35
Views
90
CrossRef citations to date
0
Altmetric
Article

Activation of the RalGEF/Ral Pathway Promotes Prostate Cancer Metastasis to Bone

, , , , , & show all
Pages 7538-7550 | Received 30 May 2007, Accepted 13 Aug 2007, Published online: 27 Mar 2023

REFERENCES

  • Akhurst, R. J., and R. Derynck. 2001. TGF-β signaling in cancer: a double-edged sword. Trends Cell Biol. 11:S44–S51.
  • Bakin, R. E., D. Gioeli, R. A. Sikes, E. A. Bissonette, and M. J. Weber. 2003. Constitutive activation of the Ras/mitogen-activated protein kinase signaling pathway promotes androgen hypersensitivity in LNCaP prostate cancer cells. Cancer Res. 63:1981–1989.
  • Bernards, R., and R. A. Weinberg. 2002. A progression puzzle. Nature 418:823.
  • Cantor, S. B., T. Urano, and L. A. Feig. 1995. Identification and characterization of Ral-binding protein 1, a potential downstream target of Ral GTPases. Mol. Cell. Biol. 15:4578–4584.
  • Chambers, A. F., A. C. Groom, and I. C. MacDonald. 2002. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2:563–572.
  • Chien, Y., and M. A. White. 2003. RAL GTPases are linchpin modulators of human tumour-cell proliferation and survival. EMBO Rep. 4:800–806.
  • Connolly, J. M., and D. P. Rose. 1998. Angiogenesis in two human prostate cancer cell lines with differing metastatic potential when growing as solid tumors in nude mice. J. Urol. 160:932–936.
  • Feig, L. A. 2003. Ral-GTPases: approaching their 15 minutes of fame. Trends Cell Biol. 13:419–425.
  • Feldman, B. J., and D. Feldman. 2001. The development of androgen-independent prostate cancer. Nat. Rev. Cancer 1:34–45.
  • Fidler, I. J. 2003. The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat. Rev. Cancer 3:453–458.
  • Fidler, I. J., and M. L. Kripke. 2003. Genomic analysis of primary tumors does not address the prevalence of metastatic cells in the population. Nat. Genet. 34:23–25.
  • Frankel, P., A. Aronheim, E. Kavanagh, M. S. Balda, K. Matter, T. D. Bunney, and C. J. Marshall. 2005. RalA interacts with ZONAB in a cell density-dependent manner and regulates its transcriptional activity. EMBO J. 24:54–62.
  • Gonzalez-Garcia, A., C. A. Pritchard, H. F. Paterson, G. Mavria, G. Stamp, and C. J. Marshall. 2005. RalGDS is required for tumor formation in a model of skin carcinogenesis. Cancer Cell 7:219–226.
  • Guise, T. A. 1997. Parathyroid hormone-related protein and bone metastases. Cancer 80:1572–1580.
  • Ikediobi, O. N., H. Davies, G. Bignell, S. Edkins, C. Stevens, S. O'Meara, T. Santarius, T. Avis, S. Barthorpe, L. Brackenbury, G. Buck, A. Butler, J. Clements, J. Cole, E. Dicks, S. Forbes, K. Gray, K. Halliday, R. Harrison, K. Hills, J. Hinton, C. Hunter, A. Jenkinson, D. Jones, V. Kosmidou, R. Lugg, A. Menzies, T. Mironenko, A. Parker, J. Perry, K. Raine, D. Richardson, R. Shepherd, A. Small, R. Smith, H. Solomon, P. Stephens, J. Teague, C. Tofts, J. Varian, T. Webb, S. West, S. Widaa, A. Yates, W. Reinhold, J. N. Weinstein, M. R. Stratton, P. A. Futreal, and R. Wooster. 2006. Mutation analysis of 24 known cancer genes in the NCI-60 cell line set. Mol. Cancer Ther. 5:2606–2612.
  • Kang, Y., P. M. Siegel, W. Shu, M. Drobnjak, S. M. Kakonen, C. Cordon-Cardo, T. A. Guise, and J. Massague. 2003. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3:537–549.
  • Lim, K. H., A. T. Baines, J. J. Fiordalisi, M. Shipitsin, L. A. Feig, A. D. Cox, C. J. Der, and C. M. Counter. 2005. Activation of RalA is critical for Ras-induced tumorigenesis of human cells. Cancer Cell 7:533–545.
  • Lim, K. H., K. O'Hayer, S. J. Adam, S. D. Kendall, P. M. Campbell, C. J. Der, and C. M. Counter. 2006. Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells. Curr. Biol. 16:2385–2394.
  • Logothetis, C. J., and S. H. Lin. 2005. Osteoblasts in prostate cancer metastasis to bone. Nat. Rev. Cancer 5:21–28.
  • Minn, A. J., G. P. Gupta, P. M. Siegel, P. D. Bos, W. Shu, D. D. Giri, A. Viale, A. B. Olshen, W. L. Gerald, and J. Massague. 2005. Genes that mediate breast cancer metastasis to lung. Nature 436:518–524.
  • Minn, A. J., Y. Kang, I. Serganova, G. P. Gupta, D. D. Giri, M. Doubrovin, V. Ponomarev, W. L. Gerald, R. Blasberg, and J. Massague. 2005. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J. Clin. Investig. 115:44–55.
  • Miric, A., M. Banks, D. Allen, J. Feighan, C. A. Petersilge, J. R. Carter, and J. T. Makley. 1998. Cortical metastatic lesions of the appendicular skeleton from tumors of known primary origin. J. Surg. Oncol. 67:255–260.
  • Moskalenko, S., D. O. Henry, C. Rosse, G. Mirey, J. H. Camonis, and M. A. White. 2002. The exocyst is a Ral effector complex. Nat. Cell Biol. 4:66–72.
  • Mundy, G. R. 2002. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat. Rev. Cancer 2:584–593.
  • Nelson, W. G., A. M. De Marzo, and W. B. Isaacs. 2003. Prostate cancer. N. Engl. J. Med. 349:366–381.
  • Nemeth, J. A., J. F. Harb, U. Barroso, Jr., Z. He, D. J. Grignon, and M. L. Cher. 1999. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone. Cancer Res. 59:1987–1993.
  • Ohta, Y., N. Suzuki, S. Nakamura, J. H. Hartwig, and T. P. Stossel. 1999. The small GTPase RalA targets filamin to induce filopodia. Proc. Natl. Acad. Sci. USA 96:2122–2128.
  • Orr, F. W., and H. H. Wang. 2001. Tumor cell interactions with the microvasculature: a rate-limiting step in metastasis. Surg. Oncol. Clin. N Am. 10:357–381.
  • Oxford, G., C. R. Owens, B. J. Titus, T. L. Foreman, M. C. Herlevsen, S. C. Smith, and D. Theodorescu. 2005. RalA and RalB: antagonistic relatives in cancer cell migration. Cancer Res. 65:7111–7120.
  • Ponomarev, V., M. Doubrovin, I. Serganova, J. Vider, A. Shavrin, T. Beresten, A. Ivanova, L. Ageyeva, V. Tourkova, J. Balatoni, W. Bornmann, R. Blasberg, and J. Gelovani Tjuvajev. 2004. A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging. Eur. J. Nucleic Med. Mol. Imaging 31:740–751.
  • Ramaswamy, S., K. N. Ross, E. S. Lander, and T. R. Golub. 2003. A molecular signature of metastasis in primary solid tumors. Nat. Genet. 33:49–54.
  • Repasky, G. A., E. J. Chenette, and C. J. Der. 2004. Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis? Trends Cell Biol. 14:639–647.
  • Rodriguez-Viciana, P., P. H. Warne, A. Khwaja, B. M. Marte, D. Pappin, P. Das, M. D. Waterfield, A. Ridley, and J. Downward. 1997. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 89:457–467.
  • Ruoslahti, E. 2004. Vascular zip codes in angiogenesis and metastasis. Biochem. Soc. Trans. 32:397–402.
  • Russell, P. J., S. Bennett, and P. Stricker. 1998. Growth factor involvement in progression of prostate cancer. Clin. Chem. 44:705–723.
  • Shipitsin, M., and L. A. Feig. 2004. RalA but not RalB enhances polarized delivery of membrane proteins to the basolateral surface of epithelial cells. Mol. Cell. Biol. 24:5746–5756.
  • Stone, K. R., D. D. Mickey, H. Wunderli, G. H. Mickey, and D. F. Paulson. 1978. Isolation of a human prostate carcinoma cell line (DU 145). Int. J. Cancer 21:274–281.
  • van 't Veer, L. J., H. Dai, M. J. van de Vijver, Y. D. He, A. A. Hart, M. Mao, H. L. Peterse, K. van der Kooy, M. J. Marton, A. T. Witteveen, G. J. Schreiber, R. M. Kerkhoven, C. Roberts, P. S. Linsley, R. Bernards, and S. H. Friend. 2002. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530–536.
  • Ward, Y., W. Wang, E. Woodhouse, I. Linnoila, L. Liotta, and K. Kelly. 2001. Signal pathways which promote invasion and metastasis: critical and distinct contributions of extracellular signal-regulated kinase and Ral-specific guanine exchange factor pathways. Mol. Cell. Biol. 21:5958–5969.
  • Weber, M. J., and D. Gioeli. 2004. Ras signaling in prostate cancer progression. J. Cell Biochem. 91:13–25.
  • Weiss, L. 1992. Comments on hematogenous metastatic patterns in humans as revealed by autopsy. Clin. Exp. Metastasis 10:191–199.
  • Weiss, L., K. Haydock, J. W. Pickren, and W. W. Lane. 1980. Organ vascularity and metastatic frequency. Am. J. Pathol. 101:101–114.
  • White, M. A., C. Nicolette, A. Minden, A. Polverino, L. Van Aelst, M. Karin, and M. H. Wigler. 1995. Multiple Ras functions can contribute to mammalian cell transformation. Cell 80:533–541.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.